{"address1": "333 Las Olas Way", "address2": "CU4 Suite 433", "city": "Fort Lauderdale", "state": "FL", "zip": "33301", "country": "United States", "phone": "954-515-0810", "website": "https://sunshinebiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Steve N. Slilaty Ph.D.", "age": 72, "title": "Chairman, President & CEO", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 640000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camille  Sebaaly", "age": 65, "title": "CFO & Secretary", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abderrazzak  Merzouki", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 340000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Malek  Chamoun", "age": 39, "title": "Chief Development Officer", "yearBorn": 1985, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michel  Roy", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Ferreira", "age": 62, "title": "President of Sunshine Bio Investments Inc", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.94, "open": 1.96, "dayLow": 1.96, "dayHigh": 2.0999, "regularMarketPreviousClose": 1.94, "regularMarketOpen": 1.96, "regularMarketDayLow": 1.96, "regularMarketDayHigh": 2.0999, "payoutRatio": 0.0, "forwardPE": 0.010410409, "volume": 180219, "regularMarketVolume": 180219, "averageVolume": 71533, "averageVolume10days": 71850, "averageDailyVolume10Day": 71850, "bid": 1.5, "ask": 2.56, "bidSize": 2, "askSize": 2, "marketCap": 5633347, "fiftyTwoWeekLow": 1.9, "fiftyTwoWeekHigh": 248.0, "priceToSalesTrailing12Months": 0.16153298, "fiftyDayAverage": 2.40066, "twoHundredDayAverage": 3.455515, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3089363, "profitMargins": -0.14722, "floatShares": 2704779, "sharesOutstanding": 2708340, "sharesShort": 113084, "sharesShortPriorMonth": 57523, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0418, "heldPercentInsiders": 0.07215, "heldPercentInstitutions": 0.01123, "shortRatio": 2.4, "shortPercentOfFloat": 0.0418, "impliedSharesOutstanding": 2806570, "bookValue": 9.103, "priceToBook": 0.2284961, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -5134116, "trailingEps": -127.9, "forwardEps": 199.8, "lastSplitFactor": "1:20", "lastSplitDate": 1723075200, "enterpriseToRevenue": -0.089, "enterpriseToEbitda": 0.553, "52WeekChange": -0.9904587, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 2.08, "targetHighPrice": 300.0, "targetLowPrice": 300.0, "targetMeanPrice": 300.0, "targetMedianPrice": 300.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 9686529, "totalCashPerShare": 3.578, "ebitda": -5588594, "totalDebt": 952480, "quickRatio": 2.146, "currentRatio": 4.112, "totalRevenue": 34874284, "debtToEquity": 4.053, "revenuePerShare": 49.696, "returnOnAssets": -0.12546, "returnOnEquity": -0.22966999, "grossProfits": 10669794, "freeCashflow": -12401965, "operatingCashflow": -12531180, "revenueGrowth": 0.249, "grossMargins": 0.30595, "ebitdaMargins": -0.16025, "operatingMargins": -0.21237, "financialCurrency": "USD", "symbol": "SBFM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1644935400000, "preMarketChange": 1.0198002, "preMarketChangePercent": 48.79427, "preMarketPrice": 3.1098, "marketState": "PRE", "regularMarketChangePercent": 7.216488, "regularMarketPrice": 2.08, "shortName": "Sunshine Biopharma Inc.", "longName": "Sunshine Biopharma, Inc.", "regularMarketChange": 0.13999987, "regularMarketDayRange": "1.96 - 2.0999", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 71533, "fiftyTwoWeekLowChange": 0.17999995, "fiftyTwoWeekLowChangePercent": 0.094736814, "fiftyTwoWeekRange": "1.9 - 248.0", "fiftyTwoWeekHighChange": -245.92, "fiftyTwoWeekHighChangePercent": -0.9916129, "fiftyTwoWeekChangePercent": -99.045876, "dividendDate": 1586131200, "earningsTimestampStart": 1743624000, "earningsTimestampEnd": 1743710400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -127.9, "epsForward": 199.8, "fiftyDayAverageChange": -0.3206601, "fiftyDayAverageChangePercent": -0.13357164, "twoHundredDayAverageChange": -1.375515, "twoHundredDayAverageChangePercent": -0.3980637, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-02-15", "corporateActions": [], "preMarketTime": 1743597264, "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_78729055", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Sunshine Biopharma", "trailingPegRatio": null}